EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis

Hasan R. Hamood

Chemical Interactions · 2026

DOI: 10.64354/4nx8w333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Interactions, 2026. Verfasst von Hasan R. Hamood. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus is related to chronic low-level inflammation that leads to metabolic perturbations. Interleukin (IL)-39 is a novel cytokine, but its involvement in the pathogenesis of inflammation and diabetes has yet to be clarified.

Objective

To measure serum IL-39 level and evaluate the diagnostic value of IL-39 in patients with diabetes mellitus.

Methods

It was a case–control study with diabetic patients and controls. Anthropometric, glycemic, lipid, and insulin resistance measurements were determined. Serum IL-39 was quantified, and the diagnostic accuracy was determined on the basis of receiver operating characteristic (ROC) curve analysis.

Results

The levels of serum IL-39 were higher in the diabetic patients than those in healthy controls (P < 0.001). The detection performance of IL-39 in the diagnosis of diabetic patients was well evaluated by ROC curve analysis with a large area under the curve. Circulating IL-39 was positively correlated with markers of glycemic disturbance and insulin resistance.

Zitieren

APA

Hamood, H. R. (2026). Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis. Chemical Interactions. https://doi.org/10.64354/4nx8w333

Vancouver

Hamood HR. Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis. Chemical Interactions. 2026. doi:10.64354/4nx8w333

BibTeX
@article{Hamood2026,
  author = {Hamood, Hasan R.},
  title = {Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis},
  journal = {Chemical Interactions},
  year = {2026},
  doi = {10.64354/4nx8w333}
}
Kostenlos starten →